External quality assessment for PML‐RARα detection in acute promyelocytic leukemia: Findings and summary

BACKGROUND: The confirmation of clinical diagnosis, molecular remission, and sequential minimal residual disease monitoring required PML‐RARα detection in acute promyelocytic leukemia (APL). The current status of PML‐RARα detection in various laboratories remains unknown. METHODS: In 2018, external...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qisheng, Zhang, Rui, Fu, Yu, Zhang, Jiawei, Chen, Kun, Li, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642306/
https://www.ncbi.nlm.nih.gov/pubmed/31131502
http://dx.doi.org/10.1002/jcla.22894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642306/
https://www.ncbi.nlm.nih.gov/pubmed/31131502
http://dx.doi.org/10.1002/jcla.22894

Ejemplares similares